Prevention and Chronic Condition Management:
Chlamydia Screening Ages 21-24
What are we measuring and why?
Chlamydia is the most common sexually transmitted disease in young women and often shows no symptoms. Although the disease can be treated, if it goes undetected it can result in significant, long-term issues including infertility and complications during pregnancy. This measure tracks the percentage of sexually active female patients ages 21 – 24 who had a screening test for Chlamydia in the last year.
How are we doing and how do we compare to best practice?
Our practices perform chlamydia screenings for our sexually active patients ages 21 – 24 at a rate of 66%, which is above the Massachusetts state average and above the National 90th percentile for this measure which is currently 61%.
What are we doing to improve?
Our physicians use electronic health record reminders and scheduling systems to ensure patients receive the appropriate screenings to detect chlamydia.
Our primary care network physicians also have access to a clinical patient registry system that identifies patients who are in need of a screening. The registry provides patient lists and contact information so that practices can contact patients and help coordinate their screenings.
Charts for Chlamydia Screening Ages 21-24
- Current Scores
- Current Scores
Chlamydia Screening Ages 21-24
Partners HealthCare Data Period: January 2010 – December 2010
Partners HealthCare Source: Partners Community HealthCare, Inc.
Mass. State Average Source: Massachusetts Health Quality Partners
National 90th Percentile Source: Massachusetts Health Quality Partners
Chlamydia Screening Ages 21-24
Partners HealthCare Data Period: January 2010 – December 2010
Partners HealthCare Source: Partners Community HealthCare, Inc.
Mass. State Average Source: Massachusetts Health Quality Partners
National 90th Percentile Source: Massachusetts Health Quality Partners